ZA201100426B - Crystalline forms of a pyridine derivative - Google Patents
Crystalline forms of a pyridine derivativeInfo
- Publication number
- ZA201100426B ZA201100426B ZA2011/00426A ZA201100426A ZA201100426B ZA 201100426 B ZA201100426 B ZA 201100426B ZA 2011/00426 A ZA2011/00426 A ZA 2011/00426A ZA 201100426 A ZA201100426 A ZA 201100426A ZA 201100426 B ZA201100426 B ZA 201100426B
- Authority
- ZA
- South Africa
- Prior art keywords
- crystalline forms
- pyridine derivative
- pyridine
- derivative
- crystalline
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0814340.6A GB0814340D0 (en) | 2008-08-05 | 2008-08-05 | Anhydrous crystol form fo a pyridine derivative |
| PCT/EP2009/060089 WO2010015626A1 (en) | 2008-08-05 | 2009-08-04 | Crystalline forms of a pyridine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201100426B true ZA201100426B (en) | 2012-03-28 |
Family
ID=39767571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2011/00426A ZA201100426B (en) | 2008-08-05 | 2011-01-17 | Crystalline forms of a pyridine derivative |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8093242B2 (enExample) |
| EP (1) | EP2321324A1 (enExample) |
| JP (1) | JP2011529942A (enExample) |
| KR (1) | KR20110052686A (enExample) |
| CN (1) | CN102171219A (enExample) |
| AU (1) | AU2009279135B2 (enExample) |
| BR (1) | BRPI0917224A2 (enExample) |
| CA (1) | CA2733235A1 (enExample) |
| EA (1) | EA201170300A1 (enExample) |
| GB (1) | GB0814340D0 (enExample) |
| IL (1) | IL210777A0 (enExample) |
| MX (1) | MX2011001414A (enExample) |
| WO (1) | WO2010015626A1 (enExample) |
| ZA (1) | ZA201100426B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2440938T3 (es) * | 2009-08-27 | 2014-01-31 | Nerre Therapeutics Limited | Formas anhidrato de un derivado de piridina |
| AU2016264034B2 (en) * | 2015-05-18 | 2020-03-05 | KaNDy Therapeutics Limited | Dual NK-1/NK-3 receptor antagonists for the treatment of sex-hormone-dependent diseases |
| EA202092131A1 (ru) | 2018-03-14 | 2020-11-27 | Кэнди Терапьютикс Лимитед | Новый фармацевтический препарат, содержащий двойные антагонисты рецептора nk-1/nk-3 |
| EP4058433A1 (en) * | 2019-11-15 | 2022-09-21 | KaNDy Therapeutics Limited | New chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of nt-814 |
| WO2025242585A1 (en) | 2024-05-24 | 2025-11-27 | Bayer Consumer Care Ag | Crystalline forms of salts of elinzanetant and compositions containing salts of elinzanetant |
| WO2025242583A1 (en) | 2024-05-24 | 2025-11-27 | Bayer Consumer Care Ag | Novel formulation comprising elinzanetant in a solid dispersion |
| US12533358B1 (en) | 2025-05-14 | 2026-01-27 | Bayer Consumer Care Ag | Methods of treatment with elinzanetant |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0912174B1 (en) | 1996-07-17 | 2004-04-28 | MERCK & CO., INC. | Alteration of circadian rhythmicity with non-peptidal neurikinin-1 receptor antagonists |
| EP1035115B1 (en) | 1999-02-24 | 2004-09-29 | F. Hoffmann-La Roche Ag | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| AU7788500A (en) | 1999-10-25 | 2001-05-08 | Janssen Pharmaceutica N.V. | Use of substance p antagonists for influencing the circadian timing system |
| GB0203020D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| GB0203022D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| TW200403058A (en) * | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| ES2291891T3 (es) * | 2003-07-03 | 2008-03-01 | F. Hoffmann-La Roche Ag | Antagonistas duales de nk1/nk3 para tratamiento de esquizofrenia. |
| DK1928886T3 (da) * | 2005-09-09 | 2011-07-11 | Glaxosmithkline Llc | Pyridin-derivater og deres anvendelse i behandlingen af psykotiske lidelser |
-
2008
- 2008-08-05 GB GBGB0814340.6A patent/GB0814340D0/en not_active Ceased
-
2009
- 2009-08-04 CN CN2009801393221A patent/CN102171219A/zh active Pending
- 2009-08-04 MX MX2011001414A patent/MX2011001414A/es unknown
- 2009-08-04 WO PCT/EP2009/060089 patent/WO2010015626A1/en not_active Ceased
- 2009-08-04 EA EA201170300A patent/EA201170300A1/ru unknown
- 2009-08-04 EP EP09781468A patent/EP2321324A1/en not_active Withdrawn
- 2009-08-04 KR KR1020117005159A patent/KR20110052686A/ko not_active Withdrawn
- 2009-08-04 CA CA2733235A patent/CA2733235A1/en not_active Abandoned
- 2009-08-04 AU AU2009279135A patent/AU2009279135B2/en not_active Ceased
- 2009-08-04 US US13/056,775 patent/US8093242B2/en active Active
- 2009-08-04 BR BRPI0917224A patent/BRPI0917224A2/pt not_active IP Right Cessation
- 2009-08-04 JP JP2011521561A patent/JP2011529942A/ja not_active Withdrawn
-
2011
- 2011-01-17 ZA ZA2011/00426A patent/ZA201100426B/en unknown
- 2011-01-20 IL IL210777A patent/IL210777A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011001414A (es) | 2011-04-04 |
| US8093242B2 (en) | 2012-01-10 |
| CN102171219A (zh) | 2011-08-31 |
| EP2321324A1 (en) | 2011-05-18 |
| AU2009279135B2 (en) | 2012-09-13 |
| AU2009279135A1 (en) | 2010-02-11 |
| GB0814340D0 (en) | 2008-09-10 |
| KR20110052686A (ko) | 2011-05-18 |
| US20110136798A1 (en) | 2011-06-09 |
| CA2733235A1 (en) | 2010-02-11 |
| BRPI0917224A2 (pt) | 2015-11-24 |
| EA201170300A1 (ru) | 2011-08-30 |
| IL210777A0 (en) | 2011-03-31 |
| WO2010015626A1 (en) | 2010-02-11 |
| JP2011529942A (ja) | 2011-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2155200T (pt) | Forma cristalina de um derivado de carbamoil-ciclohexano | |
| ZA201105479B (en) | Pyridine derivative | |
| ZA201008019B (en) | A crystalline form of posaconazole | |
| GB0819182D0 (en) | Crystalline forms | |
| SG10201500451TA (en) | Crystalline forms of a purine derivative | |
| IL212536A0 (en) | Substituted pyridines having a herbicidal effect | |
| EP2412708A4 (en) | SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE | |
| EP2514747A4 (en) | SUBSTITUTED AMINOTHIAZINE DERIVATIVE | |
| ZA201100388B (en) | Pyridine compounds | |
| IL214126A0 (en) | Crystalline insulin-conjugates | |
| IL206276A0 (en) | Pyridine derivatives | |
| ZA201200812B (en) | Anhydrate forms of a pyridine derivative | |
| IL213466A0 (en) | Spiroindolinone pyridine derivative | |
| ZA201105045B (en) | Crystalline forms of genistein | |
| IL217952A0 (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
| SI2358676T1 (sl) | Kristalinična oblika 4-(2-(2-fluorofenoksimetil)fenil)piperidinske spojine | |
| IL210777A0 (en) | Crystalline forms of a pyridine derivative | |
| GB0902406D0 (en) | Crystalline polymorphic form | |
| SI2303866T1 (sl) | Kristalne oblike natrijevega rabeprazolata | |
| IL207315A0 (en) | Piperidine derivative | |
| IL214028A0 (en) | A novel cyanopyrimidine derivative | |
| ZA201104319B (en) | Crystalline forms of a 3-carboxypropyl-aminotetralin compound | |
| IL195092A0 (en) | Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate | |
| GB0812895D0 (en) | Crystalline carbohydrate derivative | |
| HU0800755D0 (en) | Novel crystalline forms |